FDA Inspection 920586 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 3007743657

The FDA completed an inspection of Octapharma Plasma Inc on April 1, 2015 in Sioux City, IA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 1, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sioux City, IA (United States)

Citations

IDCFRDescription
324521 CFR 640.61Explanation of hazards
904421 CFR 600.10(b)Personnel capabilities